Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W McGillicuddy

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Clinics in Liver Disease|June 22, 2011
Laparoscopic liver resection in the treatment of hepatocellular carcinomaJens Mittler, John W McGillicuddy, Kenneth D Chavin
Therapeutic Drug Monitoring|February 9, 2021
Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant RecipientsDavid J Taber, Jason Hirsch, Alison Keys, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2016
Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapyRobert B Browning, John W McGillicuddy, Frank A Treiber, et al.
The Annals of Pharmacotherapy|June 9, 2020
Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled TrialJohn W McGillicuddy, Jessica L Chandler, Luke R Sox, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2021
Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trialJames N Fleming, Mulugeta Gebregziabher, Aurora Posadas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 14, 2019
Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipientsSunil D Shenvi, David J Taber, Andrew D Hardie, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 16, 2003
Flow vectorial analysis in an artificial implantable lungAkio Funakubo, Ichiro Taga, John W McGillicuddy, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipientsDavid J Taber, Nicole A Pilch, John W McGillicuddy, et al.
Surgery|November 28, 2017
Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipientsMichelle A Arms, James Fleming, Deep B Sangani, et al.
The Journal of Surgical Research|November 21, 2013
New method of stent-facilitated arterial reconstruction for orthotopic mouse liver transplantationShaotang Zhou, Arun P Palanisamy, John W McGillicuddy, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Clinics in Liver Disease|June 22, 2011
Laparoscopic liver resection in the treatment of hepatocellular carcinomaJens Mittler, John W McGillicuddy, Kenneth D Chavin
Therapeutic Drug Monitoring|February 9, 2021
Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant RecipientsDavid J Taber, Jason Hirsch, Alison Keys, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2016
Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapyRobert B Browning, John W McGillicuddy, Frank A Treiber, et al.
The Annals of Pharmacotherapy|June 9, 2020
Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled TrialJohn W McGillicuddy, Jessica L Chandler, Luke R Sox, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2021
Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trialJames N Fleming, Mulugeta Gebregziabher, Aurora Posadas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 14, 2019
Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipientsSunil D Shenvi, David J Taber, Andrew D Hardie, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 16, 2003
Flow vectorial analysis in an artificial implantable lungAkio Funakubo, Ichiro Taga, John W McGillicuddy, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipientsDavid J Taber, Nicole A Pilch, John W McGillicuddy, et al.
Surgery|November 28, 2017
Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipientsMichelle A Arms, James Fleming, Deep B Sangani, et al.
The Journal of Surgical Research|November 21, 2013
New method of stent-facilitated arterial reconstruction for orthotopic mouse liver transplantationShaotang Zhou, Arun P Palanisamy, John W McGillicuddy, et al.
Pageof 6